Found: 22
Select item for more details and to access through your institution.
Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 11, p. 2290, doi. 10.3390/jcm10112290
- By:
- Publication type:
- Article
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics †.
- Published in:
- Life (2075-1729), 2022, v. 12, n. 11, p. 1753, doi. 10.3390/life12111753
- By:
- Publication type:
- Article
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 351, doi. 10.1016/j.cllc.2020.12.008
- By:
- Publication type:
- Article
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC).
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3803, doi. 10.1007/s00262-023-03533-0
- By:
- Publication type:
- Article
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory "FoRECATT" study.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1583, doi. 10.1007/s00262-020-02788-1
- By:
- Publication type:
- Article
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery.
- Published in:
- Lung, 2022, v. 200, n. 3, p. 393, doi. 10.1007/s00408-022-00541-2
- By:
- Publication type:
- Article
Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1832, doi. 10.3390/cancers16101832
- By:
- Publication type:
- Article
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2935, doi. 10.3390/cancers13122935
- By:
- Publication type:
- Article
Prognostic Factors and Long-Term Survival in Locally Advanced NSCLC with Pathological Complete Response after Surgical Resection Following Neoadjuvant Therapy.
- Published in:
- Cancers, 2020, v. 12, n. 12, p. 3572, doi. 10.3390/cancers12123572
- By:
- Publication type:
- Article
Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1196, doi. 10.3390/cancers12051196
- By:
- Publication type:
- Article
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10997-x
- By:
- Publication type:
- Article
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10997-x
- By:
- Publication type:
- Article
The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.792385
- By:
- Publication type:
- Article
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.650293
- By:
- Publication type:
- Article
Malignant Pleural Mesothelioma: Is Tailoring the Second-Line Therapy Really "Raising the Bar?".
- Published in:
- 2019
- By:
- Publication type:
- journal article
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer.
- Published in:
- Mediators of Inflammation, 2019, p. 1, doi. 10.1155/2019/7652014
- By:
- Publication type:
- Article
Facial Papulopustular Eruption during the COVID-19 Pandemic in Patients Treated with EGFR Inhibitors.
- Published in:
- Dermatology Research & Practice, 2024, p. 1, doi. 10.1155/2024/8859032
- By:
- Publication type:
- Article
Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR -Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 277, doi. 10.3390/biomedicines10020277
- By:
- Publication type:
- Article
Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1026020
- By:
- Publication type:
- Article
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 15, p. 2611, doi. 10.1002/cncr.35293
- By:
- Publication type:
- Article
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 17, p. 9560, doi. 10.3390/ijms25179560
- By:
- Publication type:
- Article